Ardelyx, Inc. (ARDX) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $4.99 (-1.09%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Roanna Ruiz | Williams Trading | $17.00 | +241.0% |
| Jan 9, 2026 | Julian Harrison | BTIG | $17.00 | +241.0% |
| Jan 8, 2026 | Christopher Raymond | Raymond James | $19.00 | +281.1% |
| Jan 2, 2025 | Dennis Ding | Jefferies | $8.00 | +60.5% |
| Aug 5, 2024 | Ed Arce | H.C. Wainwright | $11.00 | +120.7% |
| Jul 5, 2024 | Ed Arce | H.C. Wainwright | $10.00 | +100.6% |
| May 24, 2024 | Christopher Raymond | Raymond James | $15.00 | +200.9% |
| Dec 18, 2023 | Ryan Deschner | Raymond James | $12.00 | +140.7% |
| Dec 29, 2022 | Laura Chico | Wedbush | $2.00 | -59.9% |
Top Analysts Covering ARDX
ARDX vs Sector & Market
| Metric | ARDX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +230.4% | +16365.9% | +18.0% |
| P/E Ratio | -23.61 | 3.03 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $140M | $152M | $166M | 4 |
| 2026-12-31 | $159M | $173M | $189M | 7 |
| 2027-03-31 | $121M | $131M | $144M | 4 |
| 2027-06-30 | $160M | $173M | $189M | 6 |
| 2027-09-30 | $187M | $203M | $221M | 4 |
| 2027-12-31 | $215M | $233M | $255M | 7 |
| 2028-12-31 | $980M | $980M | $980M | 8 |
| 2029-12-31 | $1.19B | $1.24B | $1.29B | 7 |
| 2030-12-31 | $1.34B | $1.40B | $1.46B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.04 | $0.05 | $0.05 | 3 |
| 2026-12-31 | $0.09 | $0.10 | $0.11 | 4 |
| 2027-03-31 | $-0.06 | $-0.05 | $-0.04 | 2 |
| 2027-06-30 | $0.08 | $0.09 | $0.10 | 2 |
| 2027-09-30 | $0.16 | $0.18 | $0.20 | 2 |
| 2027-12-31 | $0.23 | $0.25 | $0.28 | 2 |
| 2028-12-31 | $0.91 | $1.19 | $1.65 | 7 |
| 2029-12-31 | $1.71 | $1.81 | $1.90 | 2 |
| 2030-12-31 | $2.13 | $2.25 | $2.37 | 5 |
Frequently Asked Questions
What is the analyst consensus for ARDX?
The consensus among 3 analysts covering Ardelyx, Inc. (ARDX) is Buy with an average price target of $16.67.
What is the highest price target for ARDX?
The highest price target for ARDX is $19.00, set by Christopher Raymond at Raymond James on 2026-01-08.
What is the lowest price target for ARDX?
The lowest price target for ARDX is $2.00, set by Laura Chico at Wedbush on 2022-12-29.
How many analysts cover ARDX?
3 analysts have issued ratings for Ardelyx, Inc. in the past 12 months.
Is ARDX a buy or sell right now?
Based on 3 analyst ratings, ARDX has a consensus rating of Buy (2.00/5) with a +230.4% upside to the consensus target of $16.67.
What are the earnings estimates for ARDX?
Analysts estimate ARDX will report EPS of $0.05 for the period ending 2026-09-30, with revenue estimated at $152M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.